| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A need to review regulations for production and control of vaccines
|
Gupta, Rajesh K.
|
|
1997
|
15 |
1 |
p. 1-2
2 p.
|
artikel
|
| 2 |
Antibodies to OspB prevent infection of C3H mice challenged with Borrelia burgdorferi isolates expressing truncated OspB antigens
|
Probert, William Scott
|
|
1997
|
15 |
1 |
p. 15-19
5 p.
|
artikel
|
| 3 |
A recombinant canarypox virus protects rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge
|
Fischer, Laurent
|
|
1997
|
15 |
1 |
p. 90-96
7 p.
|
artikel
|
| 4 |
Author index
|
|
|
1997
|
15 |
1 |
p. I-X
nvt p.
|
artikel
|
| 5 |
Calendar
|
|
|
1997
|
15 |
1 |
p. 106-
1 p.
|
artikel
|
| 6 |
Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine
|
Deck, R.Randall
|
|
1997
|
15 |
1 |
p. 71-78
8 p.
|
artikel
|
| 7 |
Characterization of the gene encoding Mhp1 from Mycoplasma hyopneumoniae and examination of Mhp1's vaccine potential
|
King, Kendall W.
|
|
1997
|
15 |
1 |
p. 25-35
11 p.
|
artikel
|
| 8 |
Chimeric human rhinovirus with sequence encoding foreign antigen; influenza virus, polio virus-3, HIV virus-1, HIV virus-2, tumor, parasite or bacterium recombinant vaccine production using a human rhinovirus-14 vector
|
|
|
1997
|
15 |
1 |
p. 105-
1 p.
|
artikel
|
| 9 |
Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax®) in children and adults
|
Krah, David L.
|
|
1997
|
15 |
1 |
p. 61-64
4 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
1997
|
15 |
1 |
p. IFC-
1 p.
|
artikel
|
| 11 |
Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance
|
Miller, E.
|
|
1997
|
15 |
1 |
p. 51-60
10 p.
|
artikel
|
| 12 |
Immune response to a combined hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine administered to infants at 2, 4 and 6 months of age
|
Aristegui, Javier
|
|
1997
|
15 |
1 |
p. 7-9
3 p.
|
artikel
|
| 13 |
Immunogenicity of influenza vaccine (1993–1994 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users
|
Iorio, Anna M.
|
|
1997
|
15 |
1 |
p. 97-102
6 p.
|
artikel
|
| 14 |
Index to volume 14 (1996)
|
|
|
1997
|
15 |
1 |
p. I-
1 p.
|
artikel
|
| 15 |
Kinetics of immunologic responses after primary MMR vaccination
|
Pabst, Henry F.
|
|
1997
|
15 |
1 |
p. 10-14
5 p.
|
artikel
|
| 16 |
Management of animal bites and survival of rabid dogs
|
Guy Lornegan, M.D.
|
|
1997
|
15 |
1 |
p. 103-
1 p.
|
artikel
|
| 17 |
New tumor rejection antigen precursor and gene; used to develop products for the diagnosis and treatment of disorders characterized by the TRAP, particularly melanoma
|
|
|
1997
|
15 |
1 |
p. 105-
1 p.
|
artikel
|
| 18 |
Nucleotide and amino acid sequence of tumor gene; Int6 gene purification and isolation for cancer immunotherapy, diagnosis, vaccine development and gene therapy
|
|
|
1997
|
15 |
1 |
p. 105-
1 p.
|
artikel
|
| 19 |
Polymorphisms of the TAP2 gene may influence antibody response to live measles vaccine virus
|
Hayney, Mary S.
|
|
1997
|
15 |
1 |
p. 3-6
4 p.
|
artikel
|
| 20 |
Protective effect of mucosal administration of recombinant human macrophage colony-stimulating factor (rhM-CSF) on mucosal infection of Sendai virus in mice
|
Matsuzawa, Kaori
|
|
1997
|
15 |
1 |
p. 85-89
5 p.
|
artikel
|
| 21 |
Protective immunity in cattle following vaccination with conventional and marker bovine herpesvirus-1 (BHV1) vaccines
|
van Drunen Littel-van den Hurk, S.
|
|
1997
|
15 |
1 |
p. 36-44
9 p.
|
artikel
|
| 22 |
Rapid onset of malaria-induced mortality by immunizations with lipo-peptides: an experimental model to study deleterious immune responses and immunopathology in malaria
|
Reed, R.C.
|
|
1997
|
15 |
1 |
p. 65-70
6 p.
|
artikel
|
| 23 |
Recombinant vhs-defective herpes simplex virus; for use as a vaccine
|
|
|
1997
|
15 |
1 |
p. 105-
1 p.
|
artikel
|
| 24 |
Replication of hepatitis C virus in vitro; in monkey kidney or human fibroblast cell culture in serum-free medium for vaccine production
|
|
|
1997
|
15 |
1 |
p. 105-
1 p.
|
artikel
|
| 25 |
Suppression of the immune response to diphtheria toxoid in murine schistosomiasis
|
Haseeb, M.A.
|
|
1997
|
15 |
1 |
p. 45-50
6 p.
|
artikel
|
| 26 |
The B cell epitope of paramyosin recognized by a protective monoclonal IgE antibody to Schistosoma japonicum
|
Nara, Takeshi
|
|
1997
|
15 |
1 |
p. 79-84
6 p.
|
artikel
|
| 27 |
Vaccination coverage of 2-year-old children and immunization practices—Canada, 1994
|
Duclos, Philippe
|
|
1997
|
15 |
1 |
p. 20-24
5 p.
|
artikel
|
| 28 |
Vaccine 13, 811–815, 1995, letter by Dr Lonergan
|
Christopher F.Hatz, M.D.
|
|
1997
|
15 |
1 |
p. 103-
1 p.
|
artikel
|
Tijdschrift beschrijving